Alto Neuroscience (ANRO) had its price target lowered by Robert W. Baird from $41.00 to $38.00. They now have an "outperform" rating on the stock.
Alto Neuroscience (ANRO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock.
Alto Neuroscience (ANRO) had its price target lowered by JonesTrading from $49.00 to $44.00. They now have a "buy" rating on the stock.
Alto Neuroscience (ANRO) had its price target lowered by Wedbush from $22.00 to $21.00. They now have a "neutral" rating on the stock.
Alto Neuroscience (ANRO) had its "buy" rating reaffirmed by Chardan Capital. They now have a $30.00 price target on the stock.